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Abstract 
BACKGROUND: In animals and humans black raspberries (BRBs) have chemo-
preventative effects against Wnt driven colorectal cancer (CRC).  While BRBs have 
made it into clinical trials, the exact mechanisms of BRB action remain unclear.  
Potentially the chemo-preventative properties are linked to their impact on the gut 
microbiome, as diet is known to influence the microbial diversity of the gut and plays 
a key role in regulating intestinal homeostasis and the aetiology of CRC.   
OBJECTIVE:  To determine the impact of a BRB diet on the microbial biodiversity of 
the wild-type and malignant mouse intestine.  METHODS:  Adult mice in which Wnt 
driven tumourigenesis could be initiated by conditional deletion of Apc in the intestinal 
stem cell (Lgr5CreERT2) were administered a 10% BRB diet.  Total DNA from faecal 
pellets pre- and post-BRB exposure was used for longitudinal metataxonomic analysis 
of the V1 to V3 regions of the 16S rRNA gene.  
RESULTS: Individually BRB intervention and Apc loss alter the microbial community 
of the gut.  In combination, the microbiome changes observed in the Apc deficient 
intestine are attenuated upon administration of a BRB diet.  
CONCLUSIONS: Our results suggest that BRB intervention may protectively regulate 
the gut microbiota in the healthy and malignant intestine. 
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Abbreviations: 
CRC (colorectal cancer): BRB (black raspberry); HFD (high-fat diet); ISC (intestinal 
stem cell); UC (ulcerative colitis); SCFA (short chain fatty acids); AIN-76A diet 
(American Institute of Nutrition-76A diet); IP (intraperitoneal); d.p.i (days post 
induction); PCA (principle component analysis); F1 (faecal sample 1); F2 (faecal 
sample 2); F3 (faecal sample); FAP (Familial adenomatous polyposis); NS (not 
significant); DP (difference between mean proportions). 
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1. Introduction 
It is widely accepted that several factors contribute to the development of sporadic 
colorectal cancer (CRC) [1]; a leading cause of cancer death worldwide [2]. There is 
substantial evidence that genetic and epigenetic alterations [1], inflammatory bowel 
diseases [3], and environmental factors e.g. diet [4], contribute to the aetiology of CRC.  
Worldwide it is estimated that ~30-50% of all cancer cases [4] and 54% of UK CRC 
cases could have been prevented through lifestyle changes [5], emphasising the 
importance of cancer prevention. The impact of certain diets on the progression of 
CRC are beginning to be understood. For example, high-fat diets (HFD), a major 
contributor to obesity, have been shown to increase the risk of developing CRC by 
impacting on the number and tumourigenic potential of intestinal stem cells (ISCs) [6], 
the cell-of-origin of CRC [7].  In contrast, several studies have documented the 
beneficial effects of high fibre diets against CRC [8]. Dietary fibre is fermented by 
colonic microbes to produce short chain fatty acids (SCFAs) such as butyrate, which 
is a vital source of energy for colonocytes [9, 10]. Moreover, several studies have 
documented the beneficial effects of the berry fruit, including black raspberries (BRB), 
against CRC in humans and in animal models. Specifically, diets containing BRBs 
have been shown to reduce ulcerative colitis (UC) in rodent models (inflammatory 
disease) [11] and reduce CRC tumour and polyp burdens in both mice and humans 
[12-15]. While these studies have advanced our understanding of the impact of BRBs 
on CRC and have made it into clinical trials, the exact mechanisms of action remain 
unclear. However, it is likely that the gut microbiome plays a role, as diet is known to 
influence the diversity of the gut bacteria in both animals and humans [16].  This 
interaction between dietary intake and the microbiota has been well studied [17, 18] 
and it has been demonstrated in mice that the constant exposure of the large intestine 
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to ~103 different commensal bacterial species, a total of ~1014 cells, effects immune 
and inflammatory responses and cancer predisposition [9, 19-21].  The microbiome 
has an essential role in regulating normal gut homeostasis and there is a plethora of 
evidence indicating that specific microbial profiles may underpin many inflammatory 
diseases such as UC and Crohn’s disease [22], metabolic diseases such as diabetes 
[23] and is linked to obesity [24], all of which have a predisposition to CRC. For 
example, it has been shown that obese individuals have reduced numbers of 
Bacteroidetes and a decreased microbial diversity and genetic abundance, while the 
levels of Firmicutes are elevated in these obese individuals [25, 26]. In contrast, 
healthy lean individuals have a greater microbial biodiversity and an increased 
proportion of Bacteroidetes to Firmicutes [25, 26]. Interest in the gut microbiome and 
their associated metabonomes in human disease including cancer [8, 27], has placed 
emphasis on the need to further understand the complex underlying mechanisms 
involved in physiological but also pathophysiological interactions between diet-host-
microbiome.  While many studies have shown that consumption of certain dietary 
fibres and phytonutrients impacts the microbial diversity and function of the gut 
microbiota, there is limited understanding on the impact of the CRC chemo-
preventative fruit, BRBs, on the gastrointestinal microbiome.  Here, using a 
longitudinal study design we examined the impact of a black raspberry-based gut 
microbiome modulation in a CRC setting using the Lgr5CreERT2 Apcfl/fl mouse model 
of CRC, which drives tumourigenesis from the intestinal stem cell. In this study, we 
aimed to further our knowledge of the impact of BRB consumption on the gut 
microbiota in a wild type and intestine at the earliest stages of malignancy to determine 
whether the microbiome is likely to play a role in the chemo-preventative properties of 
BRBs. 
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2. METHODS 
2.1. Black raspberry (BRB) diet  
The 10% BRB diet was produced by Dyets Inc, USA. In brief, freeze-dried BRB powder 
[28] (purchased from Berrihealth USA), was incorporated into purified American 
Institute of Nutrition (AIN)-76A (protein, 20.8 kcal %; carbohydrate, 67.7% kcal %; and 
fat, 11.5 kcal %) animal diet pellets by 10% w/w concentration at the expense of 
sucrose. The BRB and control (AIN-76A) diets were stored at 4°C until being 
administered to the animals. 
 
2.2. Animals and ethics  
All animal procedures were conducted in accordance with institutional animal care and 
NC3R(UK) ARRIVE guidelines.  Work was approved under a UK Home Office Project 
license (30/3279; protocols 6 & 7) issued under the Animals (Scientific Procedures) 
Act 1986.  The animals were maintained on an outbred background and were housed 
in a standard facility. In brief, mice were maintained in conventional open top cages, 
with 2/2 spruce fir tree bedding (IPS Ltd) under a 12hr light cycle, with water and 
RM3(E) diet (expanded diet, Special Diet Services UK), ad libitum, provided for 
nutritional support. To enrich the environment, sunflower seeds (at weaning only, LBS 
Ltd), nestlets (IPS Ltd), disposable envirotubes (IPS Ltd) and small chewsticks 
(Labdiet‐IPS Ltd) were provided. At weaning age, mice were genotyped as previously 
described, for the Lgr5CreERT2 transgene [29] and for the targeted Apcfl/fl allele [30]. 
Genotyping conditions are available upon request. Adult Lgr5CreERT2 Apcfl/fl mice (11-
15 weeks, N = 4 per cohort with 2 males and 2 females in each group) were randomly 
assigned to either control (AIN-76A) or treatment (BRB) groups. Before administering 
the respective diets, faecal samples (F1) were collected from individual mice and 
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stored at −80°C. After two weeks on their respective diets, a second faecal sample 
(F2) was collected prior to inducing Apc loss in the intestinal stem cells (ISC). 
Lgr5CreERT2 Apcfl/fl mice were induced by intraperitoneal (IP) injection with 80 mg/kg 
Tamoxifen dissolved in corn oil (Sigma, UK) once daily for 4 consecutive days. This 
results in homozygous loss of the Apc allele in the ISC which leads to adenoma 
formation as previously described [7]. Twenty days post induction (d.p.i), a final faecal 
sample (F3) was collected prior to sacrifice. Mice were weighed three times a week 
from the start of the study and remained on their respective diets throughout. A 
schematic representation of the animal bioassay and comparisons analysed are 
shown in Figure 1 and Table 1 respectively. 
 
2.3. DNA extraction 
All faecal pellets were stored at −80°C immediately until required. Total bacterial DNA 
was extracted from the faecal samples using the FastDNA® SPIN Kit for Soil and the 
FastPrep® Instrument (MP Biomedicals, Santa Ana, CA), as per manufacturer details. 
DNA concentrations were quantified using the Nanodrop2000 (Thermo Scientific, UK). 
 
2.4. Sequencing and analysis of data 
Total DNA extracted from faecal pellets was used for metataxonomic analysis of the 
V1 to V3 regions of the 16S rRNA gene.  Sequence data was provided by Research 
and Testing Laboratory (Lubbock, TX, USA) as described previously [31].  The data 
was analysed using the Mothur program v 1.37.0 and the MiSeq pipeline [32].  
 
2.5. Statistics 
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Differences in the OTU data at all taxonomic levels (phylum to genus) was tested for 
the different interventions using STAMP[33] using White’s non-parametric test and 
multiple test correction using the Benjamini-Hochberg FDR test, error bars are 95% 
confidence intervals using the DP:bootstrap method (DP = difference between mean 
proportions). Analysis of difference between clusters was tested using the 
PERMANOVA test (Adonis command in Vegan package) in R. A Shapiro-Wilk 
normality test was used to determine whether mouse body weights at specific time 
points (-14, 0 and 20 d.p.i) were normally distributed. To test for significance in % body 
weight change, an unpaired t-test was used, error bars represent standard error of 
mean. Statistical significance was defined as P ≤ 0.05.  
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3. RESULTS 
3.1. Consumption of a BRB enriched diet alters the composition of the gut 
microbiome 
Previous studies have demonstrated the impact of a 10% freeze-dried BRB diet on the 
composition and diversity of mouse gut microbial communities [34].  Due to the natural 
variations that exist in murine gut microbiomes between animal facilities we first sought 
to characterise the microbiome in our mice prior to onset of cancer. Faecal pellets 
were collected from wild type (uninduced Lgr5CreERT2 Apcfl/fl (N=8)) mice prior to AIN-
76A control or BRB (ad libitum) dietary modification (F1; Fig 1).   At this stage (F1), 
PCA of mice bacterial community structure indicated no clear separation of the 
microbial communities’ present in the faeces (Fig 2, orange represents mice that will 
be fed AIN-76A control diet and blue represents mice that will be fed BRB diet).   As 
individual microbiomes were comparable, mice were exposed to control or BRB diets 
ad libitum for two weeks.  Analysis of faecal samples at the F2 sampling point (Fig 1) 
from uninduced Apcfl/fl mice 14 days after BRB dietary modification, demonstrated a 
clear shift in the composition of the microbiome in a ‘wild type’ setting (Fig 3A).  No 
individual taxonomic group, from phylum to genus level, were found to be altered when 
an FDR was applied, however pre-FDR analysis shows trends to support the 
hypothesis that BRB diet is associated with leanness after BRB fed mice appeared to 
have reduced Firmicutes and increased levels of Bacteriodetes compared to control 
(Fig 3B). To ensure there were no adverse effects of BRB intervention on murine body 
weight and to monitor symptoms of intestinal tumourigenesis, all mice were weighed 
throughout the study (Fig 4A). There was no significant difference in mouse % body 
weight at day 0, 14 and 20 d.p.i between control or BRB fed mice (Fig 4B), however, 
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on average BRB-fed mice appear to have slightly lower body weights then control fed 
mice throughout the study (Fig 4A).  
 
3.2. Loss of Apc from the intestine stem cell alters the composition of the gut 
microbiome. 
Prior to analysis of the effects of BRBs during tumourigenesis we first analysed the 
impact of ISC Apc loss on the microbiome, which mimics the initiation stages of 
colorectal tumourigenesis [7].  PCA analysis demonstrated a clear shift in the 
composition of the bacterial communities in control fed Lgr5CreERT2Apcfl/fl 20 days 
following the deletion of Apc in the ISC (comparing F2 and F3) (Fig 5A), providing 
evidence that the tumourigenic process immediately impacts the gut microbiome. 
Further analysis at taxonomic class levels reflects increases in Bacteroides and 
Clostirdium_XVIII species are the main contributors to the indicated community 
changes observed (Fig 5B).  However, due to the small number of samples (N=4) the 
changes failed to reach statistical significance when an FDR was applied. 
 
3.3. Two week BRB feeding prior to Apc loss minimizes the impact of ISC Apc 
loss on the composition of the gut microbiome. 
We next sought to address whether BRB intervention prior to the onset of intestinal 
tumourigenesis by induction of ISC Apc loss influences the microbiome of mice 20 
days post induction.   Comparison of F2 (orange) and F3 (green) faecal samples from 
BRB fed Lgr5CreERT2 Apcfl/fl mice shows a slight alteration to the gut microbiome 
composition (Fig 6). These changes in bacterial composition appear to be less than 
the change that occurs from ISC Apc loss in the control diet setting (Fig 5), which 
indicates that BRBs can attenuate the cancer-induced microbiome alterations.  Finally, 
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we wanted to evaluate whether there were any alterations to the gut cancer 
microbiome as a result of BRB exposure. Surprisingly, PCA analysis on F3 samples 
from mice showed there were no differences in the gut microbiome composition in 
tumour bearing Lgr5CreERT2 Apcfl/fl mice fed control or BRB diets at 20 days post Apc 
loss (Fig 7). 
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4. Discussion 
Chemoprevention refers to the use of naturally occurring or synthetic agents to 
reverse, suppress or delay the development of carcinogenesis [35, 36]. One of the 
growing concerns in the cancer field is the increase in cancer incidence globally, where 
there is now substantial evidence that shows the Western lifestyle is strongly 
attributable to several cancer types, in particular colon and liver cancer [4]. In the UK 
alone, it is estimated that over half of CRCs could have been prevented through 
lifestyle changes [5]. In recent years several studies have highlighted the benefits of 
natural food sources (most of which are rich fibre sources) and plant-based chemicals 
on human health and thus, these may be able to be modified for preventative 
strategies. For example, in a randomized, controlled feeding study in healthy humans, 
addition of broccoli to the diet at 200 g /day decreased the abundance of Firmicutes 
and increased the relative abundance of Bacteroidetes and Bacteroides compared to 
control [37]. This ratio of Bacteroides/Firmicutes is associated with leaner body 
weights [25, 26]. In addition, BRBs have previously been shown to reduce 
tumour/polyp burden in CRC and FAP patients and in murine models of CRC [12-14, 
38]. The chemo-preventative effects of BRBs have been attributed to several biological 
processes such as, reducing inflammation, inhibiting the Wnt signaling pathway (the 
main driver of CRC), and altering the epigenome to reactivate silenced Wnt pathway 
antagonists [11-15, 38, 39]. There is now a growing body of evidence indicating that 
our diet impacts on the gut microbiome. The commensal gut microbiota has a 
mutualistic role within our body such that it regulates gut homeostasis, aids digestion 
of indigestible fibre and helps maintain the immune system [40]. However, changes to 
the composition of the gut microbiota is known to result in dysbiosis which is strongly 
linked to several diseases including obesity, inflammatory bowel diseases and 
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ultimately CRC [22-24, 41, 42]. Due to the impact of diet on the gut microbiome it is 
possible that the chemo-preventative effects of BRBs are in part due to their effect on 
the gastrointestinal microbiota as previous studies have reported that BRBs influence 
the normal gut microbiota of healthy mice and rats [43, 44]. Thus, we sought to 
investigate what effect BRB feeding had on the microbiome in a ‘wild type’ intestine 
and what effect BRBs had on the microbiome of a transgenic murine model of CRC at 
the early stages of colorectal tumourigenesis. Herein, we report that intervention with 
BRB diet in mice alters the microbiome of the normal healthy gut. Additionally, we 
show that the gut microbiome is influenced by onset of tumourigenesis, and this 
modification to the gut microbiota may be minimised in the context of BRB feeding.  
 
It has previously been documented that the murine gut microbiota can differ depending 
on their location (i.e. which institution they are in), inter and intra-species 
heterogeneity, cage effects, diet, age and stress [45, 46]. Thus, to minimise the 
variation in the microbiota composition of the mice at the start of the experiment, we 
used age-matched litter mates from one mouse colony, which were in the same room 
on the same rack within the animal facility. In order to accurately track the changes in 
the microbiome we sampled faeces from the same mice at 3 time points throughout 
the study, to 1) determine the impact of 2-week feeding on BRB diet on the ‘normal’ 
gut microbiome, 2) to determine the impact of Apc loss in the ISC population, which 
represents the initiation stage of CRC and 3) to evaluate the effect of BRBs on the gut 
microbiome in mice after the onset of tumourigenesis when cancerous lesions are 
present in the small intestine. Our results indicate that before the commencement of 
the control AIN-76A diet or control diet supplemented with 10% freeze-dried BRBs, 
the composition of the gut microbiota was similar among all 8 healthy wild type mice 
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(uninduced Lgr5CreERT2 Apcfl/fl) (Fig 2). This highlights that any changes in the 
microbiota communities from subsequent faecal samples is from the BRB dietary 
modification and/ or the onset of tumourigenesis. Previous studies have demonstrated 
that feeding of freeze-dried BRBs and their anthocyanin-derivatives alter the microbial 
community of healthy wild type mice and rats [43, 44]. In support of this data, we also 
report herein, that 2-week feeding of BRB diet alters the composition of the murine gut 
microbiome compared to control diet (Fig 3A). However, due to the small number of 4 
mice per cohort, we were not able to detect any significant  microbial alterations at the 
Phyla or Genus level, unlike the previous studies which indicated BRBs reduce the 
abundance of Firmicutes and increased Bacteroidetes compared to the control diet 
[44], which has been observed in leaner individuals and mice [25, 47]. However, we 
report a similar trend of Bacteroidetes to Firmicutes ratio pre-FDR analysis (Fig 3B).  
Although not significantly altered after 2 weeks on the BRB diet, healthy mice with 
BRB intervention also appear to have a lower body weight on average than control fed 
mice, even after the onset of tumourigenesis (Fig 4A), which may be associated to the 
whole community shift in the microbiome and the preferential Bacteroidetes/ 
Firmicutes ratio.  
 
It is now well established that the gut microbiome is substantially altered in cancer 
patients, although it is unknown whether microbial changes have causative features 
or are a consequence of cancer onset. Several studies have documented that CRC 
patients tend to have more Fusobacteria, Proteobacteria, Clostridium, Dialister, 
Peptostreptococcus, unclassified Clostridiales and Oscillospira than control patients 
[48, 49]. However, some studies have reported contradictory findings on 
Bacteroides levels in CRC patients. While Bacteroides are usually found to be reduced 
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in abundance in CRC patients compared to control patients [50], another group 
reported that Bacteroides were increased in CRC patients [51]. It is likely that the 
composition of microbial communities is influenced by several factors including tumour 
burden and the stage of the disease and thus, results from all microbiome studies 
should be carefully interpreted. In our study, we report that 20 days after onset of 
colorectal tumourigenesis through the loss of the tumour suppressor gene Apc from 
the ISC compartment, resulted in a shift in the microbial community (Fig 5A). Contrary 
to studies which associate increased Bacteroides with healthy weights [25, 26, 50] and 
thus reduced risk of obesity and CRC, we report similar trends to Sobhani et al (2011) 
of increased Bacteroides in tumour bearing mice (Fig 5B). However, when an FDR 
was applied, these changes were not found to be significant, highlighting the need for 
larger cohort sizes in the future.  
 
We next looked to evaluate whether addition of BRBs to the diet prior to tumour onset, 
offsets the changes to the microbial community seen in the malignant setting. We 
report that the microbial composition at 20 d.p.i. in BRB-fed tumour bearing mice does 
shift from the composition observed in the same mice prior to tumour onset (Fig 6), 
however, this change in microbial community appears to be less than the shift seen in 
the control diet tumour setting (Fig 5A). This suggests that BRB intervention may limit 
the cancer-induced microbial changes and thus, may exert a protective effect against 
CRC progression, however, this needs to be investigated further. When analysing the 
effects of BRBs on the microbiome on tumour-bearing mice at 20 d.p.i compared to 
control fed tumour mice we report there were no alterations to the microbial community 
(Fig 7). This was somewhat surprising, given that the shift in the microbiome in BRB-
fed mice following Apc loss appeared to be less drastic than the shift in control fed 
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mice following Apc loss. However, as previously eluded to, the composition of 
microbial communities can be influenced by tumour burden and the stage of the 
disease. As it has been previously reported in both animal models and human patients 
that BRBs protect against CRC and FAP disease by reducing tumour/polyp burden 
[12, 14], it is possible that the lack of change in microbial communities may reflect 
differences in tumour burden in our mice.  Therefore, future studies should evaluate 
tumour burden in these cohorts.  It is also important to note, that while animal models 
have been invaluable in deciphering the mechanisms that cause cancer and have 
advanced our understanding of the microbiome, they do not fully recapitulate the 
human body, such that the site of tumourigenesis is different between human and 
mouse[52], the baseline microbiomes would be different as a result of mice having a 
vegetarian diet unlike many humans [53], and the number of tumours that form in 
Lgr5CreERT2 Apcfl/fl mice is not representative of the in vivo human setting, such that 
the induction regime used in this study results in a large tumour burden throughout the 
entire small intestine and colon [7]. Thus, in order to accurately decipher microbial 
changes and possible chemo-preventative mechanisms in the context of BRB feeding 
in the healthy and malignant gut, future studies using human faecal samples are 
essential.  
 
As demonstrated above, the mouse gut microbiome was substantially changed by 
BRBs in both the healthy intestine and following tumour onset, which may have 
protective effects against CRC initiation and progression. However, understanding the 
specific interactions between the host-gut microbiome and in the context of dietary 
modification would enable us to develop better therapeutic strategies, thus it is 
important that future studies investigate potential mechanisms in both animal models 
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but more importantly in humans. Specifically, through qRT-PCR it would be useful to 
characterise the effects of BRBs on specific microbes at the Genus level, and on the 
respective gut metabolomes in control and BRB fed mice in the healthy and malignant 
intestine. In particular analysing the levels of SCFAs, for example butyrate – a 
microbial bi-product which is the main source of colonocyte energy, that has been 
shown to be a potent histone deacetylase inhibitor (epigenetic regulator), anti-
inflammatory and have protective effects against CRC [54], would shed light on the 
impact of the microbiome and the metabolome in CRC prevention. Identifying the 
specific microbiota altered in the context of BRB intervention may enable us to 
correlate any metabolic changes to particular butyrate-producing phyla, allowing us to 
underpin the more intricate mechanisms involved in dietary cancer chemoprevention. 
In addition, given the known disturbances in epithelial barrier integrity and mucosal 
layers of the malignant gut [55] it would be interesting to evaluate if BRBs protect 
against CRC and dysbiosis by protectively regulating the epithelial barrier. Several 
studies have reported in CRC cell lines that butyrate stimulates mucus production and 
maintains epithelial integrity [56, 57], thus it may be possible that increases in butyrate-
producing microbiota may protect the intestinal epithelial from insult.   Commonly 
associated with defects in the intestinal epithelial barrier, and a common driver of CRC 
is the onset of inflammation due to the presence of bacteria in the colonic tissue [58]. 
Previously, BRBs have been shown to reduce inflammation in murine models of 
ulcerative colitis [11] and CRC [12], in rat models of oesophageal cancer [59], and 
enhance natural killer cell immunology in CRC patients [60]. Specifically, in mouse 
models of oesophageal cancer, BRBs were found to increase the expression of the 
anti-inflammatory cytokine IL-10 [59], which is associated with regulatory T cells that 
dampen inflammation and maintain immune homeostasis [61], and thus, has roles in 
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reducing cancer risk. Moreover, it has been shown that the infiltration of bacteria to 
the colonic epithelium of adenoma-bearing mice induces the expression the pro-
inflammatory cytokine Th17 [58]. IL-10 is required to suppress Th17 cell-mediated 
inflammation [62]. It may be possible that BRB intervention modifies the microbiome 
to induce the expression of IL-10 to reduce Th17-mediated inflammation. However, in 
the study by Bi et al (2010), 12-week feeding of BRBs was shown to reduce the 
expression of IL-10 in the Muc2-/- murine model of inflammation driven CRC [12], 
opposite of the effects of BRBs on IL-10 expression in oesophageal cancer, 
suggesting model-specific phenotypes. This again, highlights the importance of 
performing studies on human tissue to faithfully understand the effects and 
mechanisms of BRB intervention for CRC. Despite this, future studies using mouse 
models should also investigate the role of BRBs on microbiome-mediated 
inflammatory responses for chemoprevention. 
 
5. Conclusion 
In summary, the current study demonstrated that BRB intervention was able to alter 
the composition of the gut microbiome in healthy and intestinal tumour-bearing mice. 
These alterations in the microbial communities’ present in the bowel in the context of 
BRB chemoprevention, may elicit protective roles against colorectal carcinogenesis, 
and the microbiome itself may serve a predictive biomarker to monitor at risk patients 
of CRC development.   
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Tables 
 
Table 1 
 
Table 1:  Summary of the comparisons analysed in this longitudinal study. 
 
 
Figure Comparsion d.p.i Diet N number 
2 F1 from all uninduced Lgr5CreER
T2 Apc fl/fl  mice 
prior to start of experiment 
-14 days In house chow 
8 mice (4 put on control diet and 4 put 
on 10% BRB diet after faecal sampling 
of F1)
3 F2 from uninduced Apc fl/fl  mice 
day 0 (day of 
induction)
AIN-76A control diet vs 10% BRB 
diet 4 mice per diet cohort
5
F2 from uniduced Apc fl/fl  and F3 from induced 
Apc fl/fl  mice
day 0 vs day 20 AIN-76A control diet 4 mice per faecal timepoint
6
F2 from uniduced Apc fl/fl  and F3 from induced 
Apc fl/fl  mice
day 0 vs day 20 10% BRB diet 4 mice per faecal timepoint
7 F3 from induced Apc fl/fl mice day 20
AIN-76A control diet vs 10% BRB 
diet 4 mice per diet cohort
F1 = faecal sample 1, F2 = faecal sample 2, F3 = faecal sample 3
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Figure Captions 
Figure 1: Schematic representation of BRB exposure, recombination of Apcfl/fl alleles 
and longitudinal faecal sampling regime. 
 
Figure 2: Composition of the gut microbiota of communities are equivalent prior to BRB 
dietary modification.  A principal co-ordinate analysis (PCA) of unweighted unifrac 
distances indicating no clear separation of the microbial communities’ present in each 
animal.  This result was supported by PERMANOVA analysis in R.  Faecal samples 
of 4 uninduced control Lgr5CreERT2 Apcfl/fl () and 4 uninduced experimental 
Lgr5CreERT2Apcfl/fl () mice taken at the F1 sampling point (prior to commencement 
of BRB dietary modification). 
 
Figure 3: Consumption of a BRB diet alters microbial composition in the uninduced 
Lgr5CreERT2 Apcfl/fl intestine. A) Comparison of faecal samples taken at the F2 (; 
AIN-76A control diet) and F2 (; BRB diet) sampling point from the uninduced 
Lgr5CreERT2 Apcfl/fl cohort.  A PCA plot of the communities, based on the genera in 
each sample, indicates separation of the two groups when PC1 vs PC2 and PC1 vs 
PC3 are plotted, this result was supported by a PERMANOVA analysis in R.  B) Pre-
FDR analysis highlights 2 week feeding of BRBs resulted in an increased abundance 
of Bacteroidetes and reduced Firmicutes compared to control fed mice however, 
when an FDR is applied no one genus was shown to alter due to the feeding 
intervention, but the whole community shifted its composition in response to the BRB 
diet. N = 4 mice per cohort, error bars represent 95% confidence intervals using the 
DP:bootstrap method (DP = difference between mean proportions). 
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Figure 4: Feeding of 10% BRB diet does not alter mouse body weight over time. (A) A 
line graph showing % change in body weight over time. At time point -14 days 
uninduced Lgr5CreERT2 Apcfl/fl mice (N = 4 per cohort) were administered either 
control or BRB diet. On day 0 mice were weighed prior to Tamoxifen induction of Cre-
mediated Apc loss from the intestinal stem cell compartment. Mice were weighed 
continually until day 20 post induction were mice were culled and sampled. (B) 
Scatterplots showing at -14, 0 and 20 days post induction there was no significant 
difference in % mouse body weight of BRB fed mice compared to control fed mice. N 
= 4 mice per diet cohort, error bars represent standard error of mean, NS = not 
significant as determined by a paired t-test. 
 
Figure 5: Loss of Apc from the ISC alters the microbial composition of the Lgr5CreERT2 
Apcfl/fl intestine.  (A) A PCA plot comparing faecal communities of control diet fed 
Lgr5CreERT2 Apcfl/fl mice before (; F2) and 20 days following Apc ISC deletion (; 
F3) demonstrates a clear separation of the two groups when PC1 vs PC2 and PC1 vs 
PC3 are plotted, further supported by PERMANOVA analysis in R. (B) Classification 
of sequences by taxonomy at the class levels indicates trends to support the changes 
in overall community structure but application of a FDR indicates the changes are not 
significant as the genus level. P values are pre-FDR corrected, error bars represent 
95% confidence intervals using the DP:bootstrap method. N = 4 mice fed control diet 
per faecal sampling time point, note this is longitudinal faecal sampling from the same 
mice at different time points.  
 
Figure 6: Consumption of BRB diet prior to the loss of Apc from the ISC reduces the 
alterations to the microbial composition of the Lgr5CreERT2 Apcfl/fl intestine.  A PCA 
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plot comparing faecal communities of BRB diet fed Lgr5CreERT2 Apcfl/fl mice before 
(; F2) and 20 days following Apc ISC deletion (; F3) demonstrates a clear 
separation of the two groups when PC1 vs PC3 and PC2 vs PC3 are plotted, further 
supported by PERMANOVA analysis in R. N = 4 mice fed BRB diet per faecal sampling 
time point, note this is longitudinal faecal sampling from the same mice at different 
time points. 
 
Figure 7: Consumption of a BRB diet does not alter microbial composition in the 
Lgr5CreERT2Apcfl/fl intestine 20 days post ISC Apc loss.  Comparison of faecal 
samples taken at the F3 (; AIN-76A control diet) and F3 (; BRB diet) sampling point 
from the Lgr5CreERT2Apcfl/fl cohort.  A PCA plot of the communities for animals fed a 
BRB indicating no separation of the two groups, this result was supported by 
PERMANOVA analysis in R.  Indicating these mice were refractory to BRB induced 
microbiome changes. N = 4 mice per cohort. 
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Figure 1 
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Figure 2 
 
 
 
Uninduced Lgr5CreERT2 Apcfl/fl mice – F1 sample 
    Control mice before diet        Experimental mice before diet 
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Figure 3 
 
 
 
 
 
 
 
 
 
A     Uninduced Lgr5CreERT2 Apcfl/fl mice – F2 sample 
    Control diet            BRB diet 
 
    Control diet            BRB diet 
 
B 
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Figure 4 
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Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A     Control fed Lgr5CreERT2 mice 
B 
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Figure 6 
 
  
 
 
 
 
 
 
BRB fed Lgr5CreERT2 mice 
39 
 
Figure 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BRB fed Lgr5CreERT2 Apcfl/fl mice – F3 sample 
    Control diet            BRB diet 
 
